Originally developed for late stage metastatic melanoma, the platform tissue culture technology has also been shown to work with tumor tissues from hepatocellular carcinoma, ovarian cancer, glioblastoma multiforme, and other solid tumor cancers.
http://eon.businesswire.com/news/eon/20130731005823/en/Cancer-Immunotherapy-Platform-Targets-Broad-Range-Metastatic
http://eon.businesswire.com/news/eon/20130731005823/en/Cancer-Immunotherapy-Platform-Targets-Broad-Range-Metastatic
No comments:
Post a Comment